Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

Company Growth (employees)
Type
Public
HQ
Paris, FR
Founded
2004
Size (employees)
106,859 (est)
Sanofi was founded in 2004 and is headquartered in Paris, FR

Key People at Sanofi

Olivier Brandicourt

Olivier Brandicourt

CEO
Olivier Charmeil

Olivier Charmeil

Executive Vice President and General Manager
Jerome Contamine

Jerome Contamine

Executive Vice President & Chief Financial Officer
Karen Linehan

Karen Linehan

Executive Vice President, Legal Affairs and General Counsel
David Loew

David Loew

Executive Vice President and General Manager of Sanofi Pasteur
Philippe Luscan

Philippe Luscan

Executive Vice President, Global Industrial Affairs
Alan Main

Alan Main

Executive Vice President, Consumer Healthcare
Muzammil Mansuri

Muzammil Mansuri

Executive Vice President, Strategy & Business Development
Ameet Nathwani

Ameet Nathwani

Executive Vice President, Medical Affairs
Roberto Pucci

Roberto Pucci

Executive Vice President, Human Resources
Elias Zerhouni

Elias Zerhouni

President, Global Research & Development

Sanofi Office Locations

Sanofi has offices in Paris, Bridgewater, Macquarie Park, Ontario and in 9 other locations
Paris, FR (HQ)
54, rue La Boétie
Ho Chi Minh City, VN
10 Ham Nghi, District 1
Séoul, KR
8 Floor Handok Building, 735 Yoksam 1-Dong, Kangnam-Ku
Singapore, SG
N°6 Raffles Quay 16-00
Moscow, RU
Sadovnicheskaya str. 82, building 2, Entrance 5, 4th floor
Mexico City, MX
Avenida Universidad 1738, Col. Coyoacán
Show all (13)

Sanofi Data and Metrics

Sanofi Financial Metrics

Sanofi's revenue was reported to be €37.1 b in FY, 2015 which is a 10% increase from the previous period.
EUR

Revenue (FY, 2015)

37.1 b

Revenue growth (FY, 2014 - FY, 2015), %

10%

Gross profit (FY, 2015)

26.1 b

Gross profit margin (FY, 2015), %

71%

Net income (FY, 2015)

4.4 b

Market capitalization (25-Sep-2017)

106.3 b

Closing share price (25-Sep-2017)

84.1
Sanofi's current market capitalization is €106.3 b.
EURFY, 2013FY, 2014FY, 2015

Revenue

33 b33.8 b37.1 b

Revenue growth, %

2%10%

Cost of goods sold

10.3 b10.2 b10.9 b

Gross profit

22.6 b23.5 b26.1 b
EURFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

6.4 b6.3 b7.2 b
EURY, 2015

Revenue/Employee

365.4 k
Show all financial metrics

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Phase III Trials

11987

Projects in R&D Pipeline

36323443

Drugs Approved by FDA

1
Show all operating metrics

Sanofi Market Value History

Sanofi Revenue Breakdown

Sanofi Median Salaries

Source: 9 public H-1B filings from Sanofi

Traffic Overview of Sanofi

Sanofi Online and Social Media Presence

Sanofi Company Life and Culture

You may also be interested in